{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T04:30:20Z","timestamp":1782102620121,"version":"3.54.5"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.ygyno.2008.09.043","type":"journal-article","created":{"date-parts":[[2008,11,13]],"date-time":"2008-11-13T12:22:01Z","timestamp":1226578921000},"page":"47-54","source":"Crossref","is-referenced-by-count":30,"title":["A serum based analysis of ovarian epithelial tumorigenesis"],"prefix":"10.1016","volume":"112","author":[{"given":"Brian","family":"Nolen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Marrangoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liudmila","family":"Velikokhatnaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Prosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Winans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elesier","family":"Gorelik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lokshin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2008.09.043_bib1","unstructured":"http:\/\/www.cancer.org\/docroot\/home\/index.asp"},{"issue":"5","key":"10.1016\/j.ygyno.2008.09.043_bib2","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","article-title":"Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis","volume":"164","author":"Shih Ie","year":"2004","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.ygyno.2008.09.043_bib3","first-page":"255","article-title":"Ovarian surface epithelium: biology, endocrinology, and pathology","volume":"22","author":"Auersperg","year":"2001","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ygyno.2008.09.043_bib4","series-title":"International Hisological Classification of Tumors: Histological Typing of Ovarian Tumors","author":"Scully","year":"1999"},{"key":"10.1016\/j.ygyno.2008.09.043_bib5","series-title":"1999","article-title":"World health organization international classification of tumours","author":"Scully","year":"1999"},{"issue":"1","key":"10.1016\/j.ygyno.2008.09.043_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.pgp.0000101080.35393.16","article-title":"The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin","volume":"23","author":"Seidman","year":"2004","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"3","key":"10.1016\/j.ygyno.2008.09.043_bib7","first-page":"161","article-title":"Differential diagnosis of ovarian tumors based primarily on their patterns and cell types","volume":"18","author":"Young","year":"2001","journal-title":"Semin. Diagn. Pathol."},{"issue":"1","key":"10.1016\/j.ygyno.2008.09.043_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s007950300002","article-title":"Histological classification of ovarian cancer","volume":"36","author":"Kaku","year":"2003","journal-title":"Med. Electron. Microsc."},{"issue":"4","key":"10.1016\/j.ygyno.2008.09.043_bib9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/jcp.2006.040030","article-title":"Ovarian clear cell adenocarcinoma: a continuing enigma","volume":"60","author":"Tan","year":"2007","journal-title":"J. Clin. Pathol."},{"issue":"4","key":"10.1016\/j.ygyno.2008.09.043_bib10","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0002-9440(10)62549-7","article-title":"Diverse tumorigenic pathways in ovarian serous carcinoma","volume":"160","author":"Singer","year":"2002","journal-title":"Am. J. Pathol."},{"issue":"11","key":"10.1016\/j.ygyno.2008.09.043_bib11","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1097\/00000478-199611000-00004","article-title":"Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases","volume":"20","author":"Seidman","year":"1996","journal-title":"Am. J. Surg. Pathol."},{"issue":"6","key":"10.1016\/j.ygyno.2008.09.043_bib12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/00000478-200306000-00003","article-title":"Noninvasive and invasive micropapillary (low-grade) serous carcinoma of the ovary: a clinicopathologic analysis of 135 cases","volume":"27","author":"Smith Sehdev","year":"2003","journal-title":"Am. J. Surg. Pathol."},{"issue":"4","key":"10.1016\/j.ygyno.2008.09.043_bib13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ajog.2008.01.005","article-title":"Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis","volume":"198","author":"Kurman","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.ygyno.2008.09.043_bib14","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/1097-0142(19940401)73:7<1859::AID-CNCR2820730714>3.0.CO;2-L","article-title":"Early de novo ovarian carcinoma. A study of fourteen cases","volume":"73","author":"Bell","year":"1994","journal-title":"Cancer"},{"issue":"1\u20132","key":"10.1016\/j.ygyno.2008.09.043_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0248-4900(01)01125-X","article-title":"Eychene A: the Raf\/MEK\/ERK pathway: new concepts of activation","volume":"93","author":"Peyssonnaux","year":"2001","journal-title":"Biol. Cell"},{"issue":"3","key":"10.1016\/j.ygyno.2008.09.043_bib16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/01.pgp.0000130446.84670.93","article-title":"Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data","volume":"23","author":"Gilks","year":"2004","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"6","key":"10.1016\/j.ygyno.2008.09.043_bib17","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/jnci\/95.6.484","article-title":"Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma","volume":"95","author":"Singer","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.ygyno.2008.09.043_bib18","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ygyno.2006.05.029","article-title":"KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants","volume":"103","author":"Mayr","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2008.09.043_bib19","first-page":"2095","article-title":"Frequent PTEN\/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors","volume":"58","author":"Obata","year":"1998","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.ygyno.2008.09.043_bib20","first-page":"1344","article-title":"Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas","volume":"58","author":"Palacios","year":"1998","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.ygyno.2008.09.043_bib21","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0002-9440(10)64744-X","article-title":"Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers","volume":"156","author":"Chan","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"18","key":"10.1016\/j.ygyno.2008.09.043_bib22","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1093\/jnci\/85.18.1513","article-title":"Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer","volume":"85","author":"Kohler","year":"1993","journal-title":"J. Natl. Cancer Inst."},{"issue":"11","key":"10.1016\/j.ygyno.2008.09.043_bib23","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1073\/pnas.90.11.4961","article-title":"p53 gene mutations and protein accumulation in human ovarian cancer","volume":"90","author":"Kupryjanczyk","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.ygyno.2008.09.043_bib24","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0006-2952(97)00061-0","article-title":"Human ovarian cancer of the surface epithelium","volume":"54","author":"Berchuck","year":"1997","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.ygyno.2008.09.043_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00004347-199901000-00005","article-title":"p53 mutations and expression in ovarian cancers: correlation with overall survival","volume":"18","author":"Wen","year":"1999","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"4","key":"10.1016\/j.ygyno.2008.09.043_bib26","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/ijc.2910640412","article-title":"Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas","volume":"64","author":"Bellacosa","year":"1995","journal-title":"Int. J. Cancer"},{"issue":"12","key":"10.1016\/j.ygyno.2008.09.043_bib27","first-page":"4460","article-title":"HLA-G is a potential tumor marker in malignant ascites","volume":"9","author":"Singer","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.ygyno.2008.09.043_bib28","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1158\/0008-5472.331.65.1","article-title":"Apolipoprotein E is required for cell proliferation and survival in ovarian cancer","volume":"65","author":"Chen","year":"2005","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.ygyno.2008.09.043_bib29","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/01.pas.0000166367.68459.7d","article-title":"An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2\/neu, and C-KIT in high-grade neoplasms","volume":"29","author":"O'Neill","year":"2005","journal-title":"Am. J. Surg. Pathol."},{"issue":"4","key":"10.1016\/j.ygyno.2008.09.043_bib30","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1158\/1055-9965.EPI-04-0404","article-title":"Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer","volume":"14","author":"Gorelik","year":"2005","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2008.09.043_bib31","unstructured":"University of Pittsburgh Cancer Institute Luminex Core Facility [http:\/\/www.upci.upmc.edu\/facilities\/luminex\/sources.html]"},{"issue":"1","key":"10.1016\/j.ygyno.2008.09.043_bib32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1677\/erc.0.0060093","article-title":"The role of cytokines in both the normal and malignant ovary","volume":"6","author":"Nash","year":"1999","journal-title":"Endocr. Relat. Cancer"},{"issue":"23","key":"10.1016\/j.ygyno.2008.09.043_bib33","doi-asserted-by":"crossref","first-page":"10794","DOI":"10.1158\/0008-5472.CAN-05-0623","article-title":"Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine","volume":"65","author":"Nilsson","year":"2005","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.ygyno.2008.09.043_bib34","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.imbio.2005.07.004","article-title":"Analysis of host versus tumor interaction in cancer patients: opposing role of transforming growth factor-beta1 and interleukin-6 in the development of in situ tumor immunity","volume":"210","author":"Tsai","year":"2005","journal-title":"Immunobiology"},{"issue":"21","key":"10.1016\/j.ygyno.2008.09.043_bib35","first-page":"6959","article-title":"Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures","volume":"50","author":"Watson","year":"1990","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.ygyno.2008.09.043_bib36","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1158\/1078-0432.CCR-06-1828","article-title":"Serum cytokine profiling as a diagnostic and prognostic tool in ovarian cancer: a potential role for interleukin 7","volume":"13","author":"Lambeck","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2008.09.043_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2008.04.002","article-title":"Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus","author":"Moore","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2008.09.043_bib38","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ygyno.2007.10.017","article-title":"The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass","volume":"108","author":"Moore","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"7 Pt 1","key":"10.1016\/j.ygyno.2008.09.043_bib39","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1158\/1078-0432.CCR-05-2007","article-title":"Bead-based ELISA for validation of ovarian cancer early detection markers","volume":"12","author":"Scholler","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.ygyno.2008.09.043_bib40","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","article-title":"Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas","volume":"65","author":"Drapkin","year":"2005","journal-title":"Cancer Res."},{"issue":"1\u20132","key":"10.1016\/j.ygyno.2008.09.043_bib41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0378-1119(99)00035-9","article-title":"Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray","volume":"229","author":"Wang","year":"1999","journal-title":"Gene"},{"issue":"15","key":"10.1016\/j.ygyno.2008.09.043_bib42","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1158\/0008-5472.CAN-07-0307","article-title":"Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase","volume":"67","author":"Satpathy","year":"2007","journal-title":"Cancer Res."},{"issue":"14","key":"10.1016\/j.ygyno.2008.09.043_bib43","doi-asserted-by":"crossref","first-page":"5849","DOI":"10.1158\/0008-5472.CAN-07-6130","article-title":"Clinical and biological significance of tissue transglutaminase in ovarian carcinoma","volume":"68","author":"Hwang","year":"2008","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.ygyno.2008.09.043_bib44","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/bjc.1996.53","article-title":"The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer","volume":"73","author":"Bartlett","year":"1996","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2008.09.043_bib45","first-page":"103","article-title":"Soluble epidermal growth factor receptor (sEGFR\/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer","volume":"12","author":"Baron","year":"2003","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"4","key":"10.1016\/j.ygyno.2008.09.043_bib46","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/(SICI)1097-0215(19960822)69:4<329::AID-IJC16>3.0.CO;2-0","article-title":"Clinical significance of the tumour markers CA 125 II and CA 72-4 in ovarian carcinoma","volume":"69","author":"Hasholzner","year":"1996","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2008.09.043_bib47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF01202191","article-title":"Production of insulin-like growth factor binding proteins by human ovarian carcinoma cells","volume":"120","author":"Hofmann","year":"1994","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2008.09.043_bib48","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/humupd\/6.5.495","article-title":"Insulin-like growth factor binding protein-1 (IGFBP-1): a multifunctional role in the human female reproductive tract","volume":"6","author":"Fowler","year":"2000","journal-title":"Hum. Reprod. Updat."},{"issue":"5","key":"10.1016\/j.ygyno.2008.09.043_bib49","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1189\/jlb.1204697","article-title":"Myeloperoxidase: friend and foe","volume":"77","author":"Klebanoff","year":"2005","journal-title":"J. Leukoc. Biol."},{"issue":"4","key":"10.1016\/j.ygyno.2008.09.043_bib50","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/mutage\/gel032","article-title":"Neutrophils and respiratory tract DNA damage and mutagenesis: a review","volume":"21","author":"Knaapen","year":"2006","journal-title":"Mutagenesis"},{"issue":"4","key":"10.1016\/j.ygyno.2008.09.043_bib51","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1210\/er.2006-0036","article-title":"Gonadotropins and ovarian cancer","volume":"28","author":"Choi","year":"2007","journal-title":"Endocr. Rev."},{"issue":"6","key":"10.1016\/j.ygyno.2008.09.043_bib52","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1200\/JCO.2006.07.9970","article-title":"Early events in the pathogenesis of epithelial ovarian cancer","volume":"26","author":"Landen","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"19","key":"10.1016\/j.ygyno.2008.09.043_bib53","doi-asserted-by":"crossref","first-page":"9267","DOI":"10.1073\/pnas.89.19.9267","article-title":"AKT2, a putative oncogene encoding a member of a subfamily of protein\u2013serine\/threonine kinases, is amplified in human ovarian carcinomas","volume":"89","author":"Cheng","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808008007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808008007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T01:47:47Z","timestamp":1684633667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825808008007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0090825808008007"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2008.09.043","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}